Abstract:Author contributions: SA planned and executed the glycomic analysis, KT and LA planned and executed the glycoproteomic analysis, SH performed ELISA analysis, SR performed SPR analysis, YM and JH designed the recombinant expression and experiments executed by YM. OR, LB, RK, TS and TE were responsible for control and patient sample collection. TS and GJ contributed with design and provision of rhPRG4 for the analysis, MS and AK participated in planning and supervision of galectin-3 experiments. SF, KT and NK pe… Show more
“…To understand how the LUB brush stiffens mechanically from the binding of MB-PNA, consider that the structure of PNA is composed of four Tn antigen binding sub-unit domains . Likewise, the mucin domain of recombinant LUB, which is synthesized in tumor-derived Chinese hamster ovarian cells, is rich in core 1-type O-glycans that include Tn (and T-, sTn-, and Ts-antigen) . The capacity of PNA to bind multiple Tn antigens and the multiplicity of Tn antigen sites on the LUB mucin domain lead PNA to cross-link the LUB brush.…”
Section: Resultsmentioning
confidence: 99%
“…LUB presents largely as a freely jointed chain dominated by a ∼200 nm long, highly glycosylated mucin domain that lacks any secondary or tertiary structures. The recombinant LUB used in this study possesses a mucin domain glycosylated predominantly by small, O-linked sialylated core-1 glycans. , Connecting each side of the central mucin domain are two globular end domains, which presents sub-domains comparable to two globular proteins, hemopexin, which binds hemoglobin, and somatomedin B, a structural domain of vitronectin that plays a role in cell adhesion to the extra-cellular matrix . LUB’s end domains are strongly adhesive and consequently capable of adhering onto different surfaces, including metals, conducting polymers, and carbon-based substrates .…”
Improving outcomes for cancer patients during treatment
and monitoring
for cancer recurrence requires personalized care which can only be
achieved through regular surveillance for biomarkers. Unfortunately,
routine detection for blood-based biomarkers is cost-prohibitive using
currently specialized laboratories. Using a rapid self-assembly sensing
interface amenable to methods of mass production, we demonstrate the
ability to detect and quantify a small carbohydrate-based cancer biomarker,
Tn antigen (αGalNAc-Ser/Thr) in a small volume of blood, using
a test format strip reminiscent of a blood glucose test. The detection
of Tn antigen at picomolar levels is achieved through a new transduction
mechanism based on the impact of Tn antigen interactions on the molecular
dynamic motion of a lectin cross-linked lubricin antifouling brush.
In tests performed on retrospective blood plasma samples from patients
presenting three different tumor types, differentiation between healthy
and diseased patients was achieved, highlighting the clinical potential
for cancer monitoring.
“…To understand how the LUB brush stiffens mechanically from the binding of MB-PNA, consider that the structure of PNA is composed of four Tn antigen binding sub-unit domains . Likewise, the mucin domain of recombinant LUB, which is synthesized in tumor-derived Chinese hamster ovarian cells, is rich in core 1-type O-glycans that include Tn (and T-, sTn-, and Ts-antigen) . The capacity of PNA to bind multiple Tn antigens and the multiplicity of Tn antigen sites on the LUB mucin domain lead PNA to cross-link the LUB brush.…”
Section: Resultsmentioning
confidence: 99%
“…LUB presents largely as a freely jointed chain dominated by a ∼200 nm long, highly glycosylated mucin domain that lacks any secondary or tertiary structures. The recombinant LUB used in this study possesses a mucin domain glycosylated predominantly by small, O-linked sialylated core-1 glycans. , Connecting each side of the central mucin domain are two globular end domains, which presents sub-domains comparable to two globular proteins, hemopexin, which binds hemoglobin, and somatomedin B, a structural domain of vitronectin that plays a role in cell adhesion to the extra-cellular matrix . LUB’s end domains are strongly adhesive and consequently capable of adhering onto different surfaces, including metals, conducting polymers, and carbon-based substrates .…”
Improving outcomes for cancer patients during treatment
and monitoring
for cancer recurrence requires personalized care which can only be
achieved through regular surveillance for biomarkers. Unfortunately,
routine detection for blood-based biomarkers is cost-prohibitive using
currently specialized laboratories. Using a rapid self-assembly sensing
interface amenable to methods of mass production, we demonstrate the
ability to detect and quantify a small carbohydrate-based cancer biomarker,
Tn antigen (αGalNAc-Ser/Thr) in a small volume of blood, using
a test format strip reminiscent of a blood glucose test. The detection
of Tn antigen at picomolar levels is achieved through a new transduction
mechanism based on the impact of Tn antigen interactions on the molecular
dynamic motion of a lectin cross-linked lubricin antifouling brush.
In tests performed on retrospective blood plasma samples from patients
presenting three different tumor types, differentiation between healthy
and diseased patients was achieved, highlighting the clinical potential
for cancer monitoring.
“…In contrast to lubricin’s nonmonotonic antiadhesion properties on mucin-deficient corneal epithelial cells, dye penetrance was reduced as solution concentration increased for each lubricin variant (Figure ). The association between dye uptake and lubricin concentration is perhaps unsurprising as the presence of an oligosaccharide lattice crosslinked by galectin-3 protects against rose bengal penetrance. ,, Because galectin-3, a 35-kDa β-galactoside-binding lectin, binds lubricin O -glycans expected to be accessible on both fragments and aggregates, , we anticipated that lubricin conformation would not play a dominant role in imparting barrier functionality. Consistent with this hypothesis, the rose bengal excluded area was strongly correlated with lubricin surface coverage independent of surface conformation, with a nonparametric Spearman correlation coefficient of 0.93 ( p < 0.0001) (Figure S8A).…”
Dry
eye disease (DED) affects more than 100 million people worldwide,
causing significant patient discomfort and imposing a multi-billion-dollar
burden on global health care systems. In DED patients, the natural
biolubrication process that facilitates pain-free blinking goes awry
due to an imbalance of lipids, aqueous medium, and mucins in the tear
film, resulting in ocular surface damage. Identifying strategies to
reduce adhesion and shear stresses between the ocular surface and
the conjunctival cells lining the inside of the eyelid during blink
cycles is a promising approach to improve the signs and symptoms of
DED. However, current preclinical models for screening ocular lubricants
rely on scarce, heterogeneous tissue samples or model substrates that
do not capture the complex biochemical and biophysical cues present
at the ocular surface. To recapitulate the hierarchical architecture
and phenotype of the ocular interface for preclinical drug screening,
we developed an in vitro mucin-deficient DED model
platform that mimics the complexity of the ocular interface and investigated
its utility in biolubrication, antiadhesion, and barrier protection
studies using recombinant human lubricin, a promising investigational
therapy for DED. The biomimetic platform recapitulated the pathological
changes in biolubrication, adhesion, and barrier functionality often
observed in mucin-deficient DED patients and demonstrated that recombinant
human lubricin can reverse the damage induced by mucin loss in a dose-
and conformation-dependent manner. Taken together, these results highlight
the potential of the platformand recombinant human lubricinin
advancing the standard of care for mucin-deficient DED patients.
“…Instead of repeating these characterizations, we direct the interested readers to where specific information about LUB’s properties and chemistry can be found. A comprehensive characterization of the N-LUB and R-LUB glycomes is contained in refs and respectively. Characterization of N-LUB self-assembly, surface density, and protein adhesion resistance on Au and chemically modified Au surfaces is described in ref .…”
In
the field of bionics, the long-term effectiveness of implantable
bionic interfaces depends upon maintaining a “clean”
and unfouled electrical interface with biological tissues. Lubricin
(LUB) is an innately biocompatible glycoprotein with impressive antifouling
properties. Unlike traditional antiadhesive coatings, LUB coatings
do not passivate electrode surfaces, giving LUB coatings great potential
for controlling surface fouling of implantable electrode interfaces.
This study characterizes the antifouling properties of bovine native
LUB (N-LUB), recombinant human LUB (R-LUB), hyaluronic acid (HA),
and composite coatings of HA and R-LUB (HA/R-LUB) on gold electrodes
against human primary fibroblasts and chondrocytes in passive and
electrically stimulated environments for up to 96 h. R-LUB coatings
demonstrated highly effective antifouling properties, preventing nearly
all adhesion and proliferation of fibroblasts and chondrocytes even
under biphasic electrical stimulation. N-LUB coatings, while showing
efficacy in the short term, failed to produce sustained antifouling
properties against fibroblasts or chondrocytes over longer periods
of time. HA/R-LUB composite films also demonstrated highly effective
antifouling performance equal to the R-LUB coatings in both passive
and electrically stimulated environments. The high electrochemical
stability and long-lasting antifouling properties of R-LUB and HA/R-LUB
coatings in electrically stimulating environments reveal the potential
of these coatings for controlling unwanted cell adhesion in implantable
bionic applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.